相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
Shira Sagie et al.
CANCERS (2022)
Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
Cheng Li et al.
FRONTIERS IN SURGERY (2021)
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma
Bimal Bhindi et al.
EUROPEAN UROLOGY (2020)
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data
Roderick de Bruijn et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Complete response of renal cell carcinoma with an inferior vena cava tumor thrombus and lung metastases after treatment with nivolumab plus ipilimumab
Tomoki Okada et al.
INTERNATIONAL CANCER CONFERENCE JOURNAL (2020)
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis
Charles A. Field et al.
CLINICAL GENITOURINARY CANCER (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival
Andrew T. Lenis et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy
Craig Labbate et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib The SURTIME Randomized Clinical Trial
Axel Bex et al.
JAMA ONCOLOGY (2019)
Presurgical Pazopanib Improves Surgical Outcomes for Renal Cell Carcinoma With High-level IVC Tumor Thrombosis
Yasuyoshi Okamura et al.
IN VIVO (2019)
Remarkable effect of presurgical nivolumab on originally inoperable papillary renal cell carcinoma with tumor thrombus in inferior vena cava
Tomochika Shinagawa et al.
INTERNATIONAL CANCER CONFERENCE JOURNAL (2019)
Indications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma
Javier Gonzalez et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A. Mejean et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Sunitinib or Sorafenib as Neoadjuvant Therapy May not Improve the Survival Outcomes of Renal Cell Carcinoma with Tumor Thrombus
Wen Cai et al.
UROLOGIA INTERNATIONALIS (2018)
Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma
Ning Shao et al.
CANCER MEDICINE (2018)
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus
E. Jason Abel et al.
JOURNAL OF UROLOGY (2017)
Tumor thrombus: incidence, imaging, prognosis and treatment
Keith Bertram Quencer et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)
Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level
Qi Tang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Current Patterns of Presentation and Treatment of Renal Masses: A Clinical Research Office of the Endourological Society Prospective Study
M. Pilar Laguna et al.
JOURNAL OF ENDOUROLOGY (2014)
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
Pierre Bigot et al.
WORLD JOURNAL OF UROLOGY (2014)
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis
Che-kai Tsao et al.
WORLD JOURNAL OF UROLOGY (2013)
Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus
H. Miyake et al.
EJSO (2012)
Long-term Survival in Patients Undergoing Radical Nephrectomy and Inferior Vena Cava Thrombectomy: Single-Center Experience
Gaetano Ciancio et al.
EUROPEAN UROLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma
Bernd Wagner et al.
EUROPEAN UROLOGY (2009)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Surgery Insight: management of renal cell carcinoma with associated inferior vena cava thrombus
R. Jeffrey Karnes et al.
NATURE CLINICAL PRACTICE UROLOGY (2008)
Prognostic factors for renal cell carcinoma with tumor thrombus extension
Tobias Klatte et al.
JOURNAL OF UROLOGY (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: morbidity and long-term survival
MA Goetzl et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2004)
Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis
RC Flanigan et al.
JOURNAL OF UROLOGY (2004)
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
ML Blute et al.
BJU INTERNATIONAL (2004)
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
GHJ Mickisch et al.
LANCET (2001)
分享论文
